Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Interposer having molded low CTE dielectric
Liquid-filled protein-phosphatidic acid capsule dispersions
System and method for configuring a direct lift control system of a vehicle
Portion of a display panel with an unhappy facial expression icon
Incentive based recommendation method for mobile station content
Method for identifying bacteria in a sample
Managing a packet service call within mobile communications user equipment
  Randomly Featured Patents
Adaptive enterprise service bus (ESB) runtime system and method
Wall fishing method and apparatus
Reformer exercise apparatus
Graphic editing apparatus for adding or deleting curve to/from graphics by interactive processing
Process for extending the shelf-life of shellfish products
Press brake
Improved process for producing pure boronic and borinic esters
Electric motor drive
Disposition introduced to hydropneumatic jack
Nail polish remover composition